Market Tracker

08/24 6:18am ET

ImmunoGen Inc (NASDAQ:IMGN)

6.57
Delayed Data
As of Aug 23
 0.00 / 0.00%
Today’s Change
1.51
Today|||52-Week Range
8.04
+222.06%
Year-to-Date
No recent news for ImmunoGen Inc.

Today’s Trading

Previous close6.57
Today’s open6.57
Day’s range6.44 - 6.73
Volume1,621,111
Average volume (3 months)2,825,709
Market cap$588.7M
Dividend yield--
Data as of 08/23/2017

Growth & Valuation

Earnings growth (last year)-154.93%
Earnings growth (this year)+48.89%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-49.72%
P/E ratioNM
Price/Sales4.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTLAIntellia Therapeutic...+0.32+1.87%
AMAGAMAG Pharmaceuticals...-0.35-1.98%
ANIPANI Pharmaceuticals ...-0.59-1.29%
RXDXIgnyta Inc-0.20-2.12%
Data as of 08/23/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$43.0M
Annual profit (last year)-$157.8M
Net profit margin-366.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts